We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.
- Authors
Bellomo, R; Chapman, M; Finfer, S; Hickling, K; Myburgh, J
- Abstract
Low-dose dopamine is commonly administered to critically ill patients in the belief that it reduces the risk of renal failure by increasing renal blood flow. However, these effects have not been established in a large randomised controlled trial, and use of dopamine remains controversial. We have done a multicentre, randomised, double-blind, placebo-controlled study of low-dose dopamine in patients with at least two criteria for the systemic inflammatory response syndrome and clinical evidence of early renal dysfunction (oliguria or increase in serum creatinine concentration).
- Publication
Lancet (London, England), 2000, Vol 356, Issue 9248, p2139
- ISSN
0140-6736
- Publication type
Journal Article
- DOI
10.1016/s0140-6736(00)03495-4